Composition for therapeutic and cosmetic botulinum toxin
US8580745B2 · kind B2 · utility
8Cited by
14References
22Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 22, 2007 |
| Grant date | Nov 12, 2013 |
| Priority date | — |
| Expiry date | Jun 13, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2800/59
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to a composition of botulinum based pharmaceuticals used for therapeutic and cosmetic treatment. This invention offers an improvement on the prior art by eliminating the potential of blood-borne contamination with botulinum based pharmaceuticals. Recombinant serum albumin is taught for use in the place of human serum albumin as a stabilizing or enhancing agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.